BBH

VanEck Vectors Biotech ETF

Up$141.22
+$1.41
(+1.01%)
As of 1:00:00 AM EDT | 12/06/19  |  Market Closed

BBH Trading Data

Open

$140.15

Low Price

$140.15

High Price

$141.59

Previous Last Price

$139.82

Bid Size

$0 X 0

Ask Size

$0 X 0

BBH Portfolio Data

AUM

$372,256,700

Shares

2,647

PE Ratio

19.24

Price / Book Ratio

3.94

Expense Ratio

0.35

Net Asset Value

$140.66

Volume

Volume

8,500

Avg. Volume (YDT)

15,696

Dollar Volume

$0

Weekly Avg. Volume

13,700

Monthly Avg. Volume

14,335

Quarterly Avg. Volume

16,044

BBH Fund Description

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. Expenses for BBH are capped contractually at 0.35% until at least February 1, 2018. Cap excludes certain expenses, such as interest.

BBH Chart

BBH Summary

Fund Family

Van Eck Associates

Tracks This Index

VanEck Vectors Biotech ETF

Inception Date

2011-12-21

Asset Class

Equity

Asset Class Size

Biotech

BBH Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

BBH Holdings

Top 10 Holdings

Amgen Inc (AMGN)
11.7%
Gilead Sciences Inc (GILD)
6.89%
Vertex Pharmaceuticals Inc (VRTX)
6.03%
Biogen Inc (BIIB)
5.94%
Regeneron Pharmaceuticals Inc (REGN)
5.48%
Allergan Plc (AGN)
5.3%
Illumina Inc (ILMN)
5.17%
Incyte Corp (INCY)
5.05%
Iqvia Holdings Inc (IQV)
4.53%
Alexion Pharmaceuticals Inc (ALXN)
4.16%

Total BBH Holdings

Total Holdings: 26

Amgen Inc (AMGN)
11.7%
Gilead Sciences Inc (GILD)
6.89%
Vertex Pharmaceuticals Inc (VRTX)
6.03%
Biogen Inc (BIIB)
5.94%
Regeneron Pharmaceuticals Inc (REGN)
5.48%
Allergan Plc (AGN)
5.3%
Illumina Inc (ILMN)
5.17%
Incyte Corp (INCY)
5.05%
Iqvia Holdings Inc (IQV)
4.53%
Alexion Pharmaceuticals Inc (ALXN)
4.16%
Biomarin Pharmaceutical Inc (BMRN)
4.07%
Qiagen Nv (QGEN)
3.97%
Alnylam Pharmaceuticals Inc (ALNY)
3.91%
Beigene Ltd (BGNE)
3.79%
Exact Sciences Corp (EXAS)
3.6%
Neurocrine Biosciences Inc (NBIX)
3.43%
Sarepta Therapeutics Inc (SRPT)
3.16%
Charles River Laboratories Internationa (CRL)
3.08%
Grifols Sa (GRFS)
2.68%
Seattle Genetics Inc (SGEN)
2.6%
Ionis Pharmaceuticals Inc (IONS)
1.93%
Guardant Health Inc (GH)
1.83%
United Therapeutics Corp (UTHR)
1.25%
Bluebird Bio Inc (BLUE)
0.49%
Market Vectors Biotech ETF (BBH)
0%
Other/Cash
0%

BBH Technicals

Alpha

-9.18

Beta

1.29

Leverage

Long

Standard Deviation

4.92

BBH Dividends

Dividend Date

2018-12-20

Latest Dividend

5.551

Annual Dividend

5.55

Annual Dividend Rate

5.55

Annual Dividend Yield

3.95

BBH Performance

YTD Return

27.55%

1 Year Return

15.69%

3 Year Return

31.28%

5 Year Return

19.67%

10 Year Return

334.34%

BBH Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.